top
Search terms
Results 11 - 20 of 137 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 14
Ehjcvp

Hypertension constitutes a major risk factor for cardiovascular mortality, myocardial infarction, heart failure, stroke, atrial fibrillation, and peripheral arterial disease, with one billion people ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Vasiliki Katsi, Georgios Skalis, Antonis N. Pavlidis, Thomas Makris, Petros Nihoyannopoulos, Dimitris Tousoulis, Ioannis Kallikazaros

Date : 01/10/2015 Item size : 268677 bytes
Ehjcvp

Despite treatments for secondary prevention, patients with prior myocardial infarction (MI) remain at high risk for recurrent thrombotic events.1 The addition of a P2Y12 receptor antagonist to ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Giulia Magnani, Marc P. Bonaca, Marc S. Sabatine

Date : 01/10/2015 Item size : 188203 bytes
Ehjcvp

Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival Abstract Aims Treatment with evidence-based heart failure (HF) medication ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Christoffer Tobias Witt, Mads Brix Kronborg, Ellen Aagaard Nohr, Peter Thomas Mortensen, Christian Gerdes, Jens Cosedis ...

Date : 01/07/2015 Item size : 273569 bytes
Ehjcvp

Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease Cases were patients with coronary artery disease (CAD) ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Stéphane Manzo-Silberman, Pascale Nicaise-Roland, Catherine Neukirch, Florence Tubach, Marie-Geneviève Huisse, Sylvie ...

Date : 05/08/2016 Item size : 209243 bytes
Ehjcvp

Introduction While rates of death due to cardiovascular diseases have declined over the past decades in both the USA and Europe, the attributable burden remains high.1,2 Among these, acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, J. Wouter Jukema, Maddalena Lettino, Petr Widimský, Nicolas Danchin, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, ...

Date : 01/10/2015 Item size : 496391 bytes
Ehjcvp

Recent data from seven European countries show a much better adherence to evidence and recommendations for oral anticoagulation.1 Interestingly, NOACs were given to younger patients and only to 6% of ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Rocio Hinojar, Jose Julio Jiménez-Natcher, Covadonga Fernández-Golfín, Jose Luis Zamorano

Date : 01/04/2015 Item size : 312462 bytes
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 01/10/2016 Item size : 282882 bytes
Ehjcvp

The WG contributes to most ESC guidelines with expertise on cardiovascular pharmacotherapy. [...]over the last 2 years the WG has beenor is stillinvolved in eight ESC guidelines. Gender differences ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Keld Kjeldsen

Date : 01/01/2015 Item size : 98083 bytes
Ehjcvp

In a meta-analysis, in this issue of the journal, Kuljit Singh and co-workers from the University of Ottawa Heart Institute in Canada report that despite rapid revascularization and treatment of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefan Agewall

Date : 01/10/2015 Item size : 96385 bytes
Ehjcvp

[...]we have to recognize the pivotal role of the pharmaceutical industry in biomedical research since, given the lack of public funding, the majority of funded clinical trials in Europe and in the ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Giuseppe M.C. Rosano, Claudio Ceconi

Date : 01/04/2015 Item size : 102016 bytes